Literature DB >> 18391510

Single nucleotide polymorphisms of the pregnane x receptor gene in Han Chinese and a comparison with other ethnic populations.

Xue-Ding Wang1, Xiao-Ying Deng, Jie Chen, Jia-Li Li, Xiao Chen, Li-Zi Zhao, Yan Lu, Balram Chowbay, Qi-Biao Su, Min Huang, Shu-Feng Zhou.   

Abstract

The pregnane X receptor (PXR/NR1I2) gene is a master regulator for a number of cytochrome P450s (CYPs) and drug transporters. This study aimed to detect the single nucleotide polymorphisms (SNPs) of the PXR gene in Han Chinese (n = 186) and to compare the frequencies of polymorphisms of the PXR gene with those in Caucasian and African Americans reported in the literature. The SNPs of the PXR gene were analyzed using the polymerase chain reaction (PCR) and direct sequencing analysis. The mutant frequencies of A11156C and T11193C in Han Chinese were 55% (95% confidence interval (CI): 0.49-0.61) and 59% (95% CI: 0.52-0.64), respectively, higher than those of Caucasian Americans (16 and 16%, respectively) and African Americans (33 and 30%, respectively). However, the reported SNPs in exons 2 and 4 (PXR*2,*3,*4,*6,*9,*10,and *11) were not detected in Han Chinese. These results indicate that there are marked differences in the mutant frequencies of A11156C and T11193C of PXR between Han Chinese and other ethnic groups. The mutant frequency in the coding region (exons 2 and 4) of PXR was very low in Han Chinese. Further studies are needed to determine the impact of common SNPs of PXR in Han Chinese and other ethnic populations on the phenotypic activity of cytochrome P450s and drug transporters transactivated by PXR. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391510     DOI: 10.1159/000123687

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

Review 1.  Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors:  Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

2.  PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin.

Authors:  Rita Piedade; Elke Schaeffeler; Stefan Winter; Sara Asimus; Matthias Schwab; Michael Ashton; Oliver Burk; José P Gil
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

3.  Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.

Authors:  Rui Liu; Zi-Yi Zhou; Yi-Bei Chen; Jia-Li Li; Wei-Bang Yu; Xin-Meng Chen; Min Zhao; Yuan-Qi Zhao; Ye-Feng Cai; Jing Jin; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

4.  Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.

Authors:  Yu Zhang; Jia-li Li; Qian Fu; Xue-ding Wang; Long-shan Liu; Chang-xi Wang; Wen Xie; Zhuo-jia Chen; Wen-ying Shu; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2013-03-18       Impact factor: 6.150

5.  Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.

Authors:  Wenying Shu; Su Guan; Xiuyan Yang; Liuqin Liang; Jiali Li; Zhuojia Chen; Yu Zhang; Lingyan Chen; Xueding Wang; Min Huang
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

6.  Frequency of genetic polymorphisms of PXR gene in the Brazilian population.

Authors:  Ricardo P P Moreira; Alexander A L Jorge; Berenice B Mendonca; Tânia A S S Bachega
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Effect of Pregnane X Receptor*1B genetic polymorphisms on postoperative analgesia with fentanyl in Chinese patients undergoing gynecological surgery.

Authors:  Jing-Jing Yuan; Xiao-Jing Ma; Zhi-Song Li; Yan-Zi Chang; Wei Zhang; Quan-Cheng Kan; Jun-Kai Hou; Li-Rong Zhang
Journal:  BMC Med Genet       Date:  2016-11-23       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.